Re: ZEN-3694 Single Agent Trial Status
in response to
by
posted on
Jul 15, 2017 12:58PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Next
Yes, this is the expectation that Don set up and now is leaving us in the dark. Bear has provided excellent summaries of the status as we know it but even BDAZ points out the missing information.
It is very frustrating but typical of Don in terms of sort of creating an expectation and then not delivering.
Toinv